A study suggests that a reduced dose of enfortumab vedotin may lower toxicity in older patients with urothelial carcinoma, ...

Bladder and Urothelial Cancer Trials to Watch at ESMO 2026 / bladder cancer, cancer, cancer care, Cancer research, cancer ...

Astellas Announced Presentation of 21 Abstracts at ESMO 2026 Including Prostate, Urothelial, GEJ, Lung and Pancreatic cancers ...

Global Urothelial Cancer Drugs Market was valued at USD 4.03 Billion in 2025 and is expected to grow at 11.34% CAGR to reach USD 11.81 Billion by 2035.

In Part 1, I wrote about how cancers of the urinary tract present with the sign of "painless, yet intermittent" hematuria, ...

A new review in Medical Oncology maps how the tumor microenvironment and gut microbiome drive resistance to immune checkpoint ...

Researchers built a four-gene signature based on propionate metabolism that stratifies colorectal cancer patients by survival ...

Starting tomorrow, National Health Insurance will be applied, virtually for the first time, to a combination therapy that ...

The new clinical guideline was developed by a multidisciplinary task force of radiation, medical, and urologic oncologists, a medical physicist, and a patient representative who reviewed published ...

South Korea expands insurance to cover three cancer drugs and first combo Coverage widens from October for Retsevmo, Vyloy, ...

ICI unmet need through differentiated, biomarker-guided therapies, strategic pipeline prioritization, competitive benchmarking, and market access planning across the 7MM.Dublin, Sept. 30, 2026 (GLOBE ...